191 related articles for article (PubMed ID: 25324322)
1. Low utilisation of diabetes medicines in Iran, despite their affordability (2000-2012): a time-series and benchmarking study.
Sarayani A; Rashidian A; Gholami K
BMJ Open; 2014 Oct; 4(10):e005859. PubMed ID: 25324322
[TBL] [Abstract][Full Text] [Related]
2. Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Chow CK; Ramasundarahettige C; Hu W; AlHabib KF; Avezum A; Cheng X; Chifamba J; Dagenais G; Dans A; Egbujie BA; Gupta R; Iqbal R; Ismail N; Keskinler MV; Khatib R; Kruger L; Kumar R; Lanas F; Lear S; Lopez-Jaramillo P; McKee M; Mohammadifard N; Mohan V; Mony P; Orlandini A; Rosengren A; Vijayakumar K; Wei L; Yeates K; Yusoff K; Yusuf R; Yusufali A; Zatonska K; Zhou Y; Islam S; Corsi D; Rangarajan S; Teo K; Gerstein HC; Yusuf S;
Lancet Diabetes Endocrinol; 2018 Oct; 6(10):798-808. PubMed ID: 30170949
[TBL] [Abstract][Full Text] [Related]
3. Selection of essential medicines for diabetes in low and middle income countries: a survey of 32 national essential medicines lists.
Bazargani YT; de Boer A; Leufkens HG; Mantel-Teeuwisse AK
PLoS One; 2014; 9(9):e106072. PubMed ID: 25259517
[TBL] [Abstract][Full Text] [Related]
4. Despite Affordability, Low Utilization of Lipid Lowering Drugs in Iran: Trend Analysis and Benchmarking 2005-2016.
Zartab S; Abbassian H; Nassiri Koopaei N; Hajimolaali M
Iran J Pharm Res; 2019; 18(2):1117-1125. PubMed ID: 31531093
[TBL] [Abstract][Full Text] [Related]
5. Affordability of Medication Therapy in Diabetic Patients: A Scenario-Based Assessment in Iran's Health System Context.
Zarei L; Peymani P; Moradi N; Kheirandish M; Mirjalili M; Zare M
Int J Health Policy Manag; 2022 Apr; 11(4):443-452. PubMed ID: 32861229
[TBL] [Abstract][Full Text] [Related]
6. Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and Affordability.
Husain MJ; Datta BK; Kostova D; Joseph KT; Asma S; Richter P; Jaffe MG; Kishore SP
J Am Heart Assoc; 2020 May; 9(9):e015302. PubMed ID: 32338557
[TBL] [Abstract][Full Text] [Related]
7. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study.
Kibirige D; Atuhe D; Kampiire L; Kiggundu DS; Donggo P; Nabbaale J; Mwebaze RM; Kalyesubula R; Lumu W
Int J Equity Health; 2017 Aug; 16(1):154. PubMed ID: 28836972
[TBL] [Abstract][Full Text] [Related]
8. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon.
Jingi AM; Noubiap JJ; Ewane Onana A; Nansseu JR; Wang B; Kingue S; Kengne AP
PLoS One; 2014; 9(11):e111812. PubMed ID: 25369455
[TBL] [Abstract][Full Text] [Related]
9. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
[TBL] [Abstract][Full Text] [Related]
10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
11. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
12. Evaluating access to oral anti-diabetic medicines: A cross-sectional survey of prices, availability and affordability in Shaanxi Province, Western China.
Yang C; Hu S; Zhu Y; Zhu W; Li Z; Fang Y
PLoS One; 2019; 14(10):e0223769. PubMed ID: 31618273
[TBL] [Abstract][Full Text] [Related]
13. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
15. Affordability of essential medicines: The case of fluoride toothpaste in 78 countries.
Gkekas A; Varenne B; Stauf N; Benzian H; Listl S
PLoS One; 2022; 17(10):e0275111. PubMed ID: 36260605
[TBL] [Abstract][Full Text] [Related]
16. The availability, pricing and affordability of three essential asthma medicines in 52 low- and middle-income countries.
Babar ZU; Lessing C; Mace C; Bissell K
Pharmacoeconomics; 2013 Nov; 31(11):1063-82. PubMed ID: 24127259
[TBL] [Abstract][Full Text] [Related]
17. Outpatient cardiovascular diseases and diabetes medicines dispensing in the population with government health insurance in Syria between 2018 and 2019: a retrospective analysis.
Aljadeeah S; Nagel E; Wirtz VJ
BMC Health Serv Res; 2021 Oct; 21(1):1088. PubMed ID: 34645430
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic Utilization in Iran 2000-2016: Pattern Analysis and Benchmarking with Organization for Economic Co-operation and Development Countries.
Abbasian H; Hajimolaali M; Yektadoost A; Zartab S
J Res Pharm Pract; 2019; 8(3):162-167. PubMed ID: 31728348
[TBL] [Abstract][Full Text] [Related]
19. Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the 'Farmácia Popular' programme in Brazil.
Emmerick ICM; Campos MR; Luiza VL; Chaves LA; Bertoldi AD; Ross-Degnan D
BMJ Open; 2017 Nov; 7(11):e017308. PubMed ID: 29101135
[TBL] [Abstract][Full Text] [Related]
20. Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa.
Kibirige D; Olum R; Kyazze AP; Bongomin F; Sanya RE
Trop Med Int Health; 2022 Nov; 27(11):942-960. PubMed ID: 36121433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
